Medicare Updated Articles Display Page

JF LOB Updated Artcles
Article ID Modified By Modified On Title
30395511 James Marko 2026-09-24 12:07:24.513 Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease (A59868) - R3 - Effective October 1, 2026
30395358 James Marko 2026-09-24 11:58:37.108 Billing and Coding: MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis (A60217) - R1 - Effective October 1, 2026
30395716 James Marko 2026-09-24 13:21:02.841 Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57891) - R14 - Effective October 1, 2026
30391840 James Marko 2026-09-23 14:01:04.755 Avoid Common CMS 2540-24 Cost Report Errors
30395631 James Marko 2026-09-24 13:15:12.57 Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors (A57901) - R10 - Effective May 17, 2020
30395494 James Marko 2026-09-24 12:07:22.7 Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease (A59868) - R3 - Effective October 1, 2026
30395579 James Marko 2026-09-24 12:11:20.254 Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis (A59872) - R3 - Effective October 1, 2026
30392290 James Marko 2026-09-24 11:54:23.918 Billing and Coding: MolDX: BCR-ABL (A55595) - R3 - Effective September 24, 2026
30395375 James Marko 2026-09-24 11:58:38.383 Billing and Coding: MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis (A60217) - R1 - Effective October 1, 2026
30395443 James Marko 2026-09-24 12:03:05.206 Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment (A57037) - R9 - Effective October 1, 2026
30395648 James Marko 2026-09-24 13:15:13.889 Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors (A57901) - R10 - Effective May 17, 2020
30395562 James Marko 2026-09-24 12:11:18.64 Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis (A59872) - R3 - Effective October 1, 2026
30395699 James Marko 2026-09-24 13:21:01.61 Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57891) - R14 - Effective October 1, 2026
30395307 James Marko 2026-09-24 11:54:25.139 Billing and Coding: MolDX: BCR-ABL (A55595) - R3 - Effective September 24, 2026
30395426 James Marko 2026-09-24 12:03:03.522 Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment (A57037) - R9 - Effective October 1, 2026
JD LOB Updated Artcles
Article ID Modified By Modified On Title
30392151 James Marko 2026-09-23 18:51:12.304 Required List for Face-to-Face Encounter (F2F) and Written Order Prior to Delivery (WOPD) Update Effective October 28, 2026
30392037 Kirby Schwartzbauer 2026-09-23 15:32:27.182 Don't Get Caught Off Guard: CMS Expands Authorization Requirements for 2026
30392074 James Marko 2026-09-23 15:34:21.653 Therapeutic Shoes for Persons with Diabetes (TSPD) Self-Paced Tutorials
30391744 Kirby Schwartzbauer 2026-09-22 17:53:29.675 Enteral Nutrition Billing Basics: Understanding Units of Service and Date Span Requirements
30387062 James Marko 2026-09-18 15:06:29.998 Wheelchair Updates Effective October 28, 2026
JE LOB Updated Artcles
Article ID Modified By Modified On Title
30395341 James Marko 2026-09-24 11:58:36.02 Billing and Coding: MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis (A60217) - R1 - Effective October 1, 2026
30395682 James Marko 2026-09-24 13:21:00.135 Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57891) - R14 - Effective October 1, 2026
30391857 James Marko 2026-09-23 14:01:06.088 Avoid Common CMS 2540-24 Cost Report Errors
30392256 James Marko 2026-09-24 11:54:21.72 Billing and Coding: MolDX: BCR-ABL (A55595) - R3 - Effective September 24, 2026
30395528 James Marko 2026-09-24 12:11:15.781 Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis (A59872) - R3 - Effective October 1, 2026
30395460 James Marko 2026-09-24 12:07:19.143 Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease (A59868) - R3 - Effective October 1, 2026
30395409 James Marko 2026-09-24 12:03:01.827 Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment (A57037) - R9 - Effective October 1, 2026
30395324 James Marko 2026-09-24 11:58:34.462 Billing and Coding: MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis (A60217) - R1 - Effective October 1, 2026
30395597 James Marko 2026-09-24 13:15:09.78 Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors (A57901) - R10 - Effective May 17, 2020
30395392 James Marko 2026-09-24 12:02:59.921 Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment (A57037) - R9 - Effective October 1, 2026
30395614 James Marko 2026-09-24 13:15:11.13 Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors (A57901) - R10 - Effective May 17, 2020
30395545 James Marko 2026-09-24 12:11:17.175 Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis (A59872) - R3 - Effective October 1, 2026
30395477 James Marko 2026-09-24 12:07:20.781 Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease (A59868) - R3 - Effective October 1, 2026
30395665 James Marko 2026-09-24 13:20:58.896 Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57891) - R14 - Effective October 1, 2026
30392273 James Marko 2026-09-24 11:54:22.723 Billing and Coding: MolDX: BCR-ABL (A55595) - R3 - Effective September 24, 2026
JA LOB Updated Artcles
Article ID Modified By Modified On Title
30391732 Kirby Schwartzbauer 2026-09-22 17:53:19.48 Enteral Nutrition Billing Basics: Understanding Units of Service and Date Span Requirements
30392128 James Marko 2026-09-23 18:51:11.181 Required List for Face-to-Face Encounter (F2F) and Written Order Prior to Delivery (WOPD) Update Effective October 28, 2026
30387079 James Marko 2026-09-18 15:06:27.328 Wheelchair Updates Effective October 28, 2026
30392025 Kirby Schwartzbauer 2026-09-23 15:32:23.92 Don't Get Caught Off Guard: CMS Expands Authorization Requirements for 2026
30392057 James Marko 2026-09-23 15:34:20.519 Therapeutic Shoes for Persons with Diabetes (TSPD) Self-Paced Tutorials